Gaudium Ivf And Women Health Ltd vs Yatharth Hospital Trauma Care Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Gaudium IVF and Women Health Ltd is ₹ 105.75 as of 30 Oct 15:30 . The P/E Ratio of Gaudium IVF and Women Health Ltd changed from 21.2 on March 2026 to 21.2 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Yatharth Hospital & Trauma Care Services Ltd changed from 31.3 on March 2024 to 33.9 on March 2026 . This represents a CAGR of 2.70% over 3 years The Market Cap of Gaudium IVF and Women Health Ltd changed from ₹ 519.04 crore on March 2026 to ₹ 519.04 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 3582 crore on March 2024 to ₹ 5946 crore on March 2026 . This represents a CAGR of 18.40% over 3 years The revenue of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 20.5 crore as compare to the Mar '26 revenue of ₹ 30.53 crore. This represent the decline of -32.85% The revenue of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 397.01 crore as compare to the Mar '26 revenue of ₹ 348.67 crore. This represent the growth of 13.86% The ebitda of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 3.55 crore as compare to the Mar '26 ebitda of ₹ 12.35 crore. This represent the decline of -71.26% The ebitda of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 96.04 crore as compare to the Mar '26 ebitda of ₹ 87.02 crore. This represent the growth of 10.37% The net profit of Gaudium IVF and Women Health Ltd changed from ₹ 3.4 crore to ₹ 1.78 crore over 7 quarters. This represents a CAGR of -30.91% The net profit of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 30.38 crore to ₹ 45.42 crore over 9 quarters. This represents a CAGR of 19.57% The Dividend Payout of Gaudium IVF and Women Health Ltd changed from 47.88 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Yatharth Hospital & Trauma Care Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana.
Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center. Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years.
Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited.

About Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008.
On November 3, 2021, the status converted into a Public Company and name of the Company was changed to Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC. Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh.
The super speciality tertiary care hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities.

FAQs for the comparison of Gaudium IVF and Women Health Ltd and Yatharth Hospital & Trauma Care Services Ltd

Which company has a larger market capitalization, Gaudium IVF and Women Health Ltd or Yatharth Hospital & Trauma Care Services Ltd?

Market cap of Gaudium IVF and Women Health Ltd is 769 Cr while Market cap of Yatharth Hospital & Trauma Care Services Ltd is 8,942 Cr

What are the key factors driving the stock performance of Gaudium IVF and Women Health Ltd and Yatharth Hospital & Trauma Care Services Ltd?

The stock performance of Gaudium IVF and Women Health Ltd and Yatharth Hospital & Trauma Care Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gaudium IVF and Women Health Ltd and Yatharth Hospital & Trauma Care Services Ltd?

As of November 1, 2026, the Gaudium IVF and Women Health Ltd stock price is INR ₹105.75. On the other hand, Yatharth Hospital & Trauma Care Services Ltd stock price is INR ₹928.05.

How do dividend payouts of Gaudium IVF and Women Health Ltd and Yatharth Hospital & Trauma Care Services Ltd compare?

To compare the dividend payouts of Gaudium IVF and Women Health Ltd and Yatharth Hospital & Trauma Care Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.